Valuation (26%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.35 | N/A |
| PEG Ratio (TTM) | 0.47 | N/A |
| P/S Ratio (TTM) | 363.48 | N/A |
| P/B Ratio (TTM) | 1.43 | N/A |
| P/FCF Ratio (TTM) | -8.88 | N/A |
| Price to 5YR AVG Earnings Ratio | -7.59 | N/A |
| Price to 5YR AVG FCF Ratio | -14.96 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -93.13% | N/A |
| ROE (TTM) | -108.68% | N/A |
| Net Profit Margin (TTM) | -21,940.68% | N/A |
| ROIC 5YR AVG | -19.04% | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -646.33% | -453.83% | -269.87% |
| Revenue | -37.33% | N/A | N/A |
| Net Income | -728.25% | -1,133.95% | -679.71% |
| Cash Flow | -29.62% | -1,334.14% | -802.82% |
Health (60%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 9.57 | N/A |
| Quick Ratio (TTM) | 9.57 | N/A |
| D/E Ratio (TTM) | 0.02 | N/A |
| Interest Coverage (TTM) | -26.64 | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | 3.70 | N/A |
| LTL to 5YR AVG FCF | -0.03 | N/A |
| Shares Outstanding Growth 5YR AVG | 43.16% | N/A |